Shaanxi Micot Pharmaceutical Technology Co., Ltd. (HKG:2335)

HKG:2335 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jul 2, 2026	Dec 31, 2025	Dec 31, 2024
Debt / Equity Ratio	-1.26	-1.26	0.59
Net Debt / Equity Ratio	-1.01	-1.01	-0.83
Net Debt / EBITDA Ratio	-6.48	-6.48	0.87
Net Debt / FCF Ratio	-7.05	-7.05	0.96
Quick Ratio	0.89	0.89	2.31
Current Ratio	0.98	0.98	2.39
Return on Assets (ROA)	-33.17%	-33.17%	-
Return on Capital Employed (ROCE)	-236.10%	-236.10%	-74.30%
Buyback Yield / Dilution	-	-3.71%	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every year for this company.

Update frequency:

Yearly

Last checked:

Jul 1, 2026

Data Sources Report a data error